166 related articles for article (PubMed ID: 37817210)
1. Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma.
Zhang Y; Sun S; Qi Y; Dai Y; Hao Y; Xin M; Xu R; Chen H; Wu X; Liu Q; Kong C; Zhang G; Wang P; Guo Q
J Ovarian Res; 2023 Oct; 16(1):200. PubMed ID: 37817210
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
Lin X; Tang X; Zheng T; Qiu J; Hua K
J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1
Zhang T; Yang J; Sun Y; Song J; Gao D; Huang S; Pang A; Zhang J; Wang J; Wang Y; Li Y
Anal Cell Pathol (Amst); 2023; 2023():8334881. PubMed ID: 36814597
[TBL] [Abstract][Full Text] [Related]
5. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
6. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
7. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.
Li Y; Wang W; Wang D; Zhang L; Wang X; He J; Cao L; Li K; Xie H
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553542
[TBL] [Abstract][Full Text] [Related]
9. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Yue H; Li W; Chen R; Wang J; Lu X; Li J
Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer.
Yu S; Yang R; Xu T; Li X; Wu S; Zhang J
Gynecol Oncol; 2022 Nov; 167(2):342-353. PubMed ID: 36114029
[TBL] [Abstract][Full Text] [Related]
11. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts.
Dong T; Yang D; Li R; Zhang L; Zhao H; Shen Y; Zhang X; Kong B; Wang L
Exp Mol Pathol; 2016 Feb; 100(1):17-25. PubMed ID: 26607602
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
Cai W; Zhang Q
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
14. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract][Full Text] [Related]
16. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
Cao Y; Shi H; Ren F; Jia Y; Zhang R
Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
[TBL] [Abstract][Full Text] [Related]
18. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
19. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
Sun Y; Hu L; Zheng H; Bagnoli M; Guo Y; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Ji P; Chen K; Sood AK; Mezzanzanica D; Liu J; Sun B; Zhang W
J Pathol; 2015 Jan; 235(1):25-36. PubMed ID: 25230372
[TBL] [Abstract][Full Text] [Related]
20. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
